>
4回膜貫通型タンパク質Claudin18.2(HEK293に発現)
分子 | 製品番号 | 詳細 | 用途 | 注文/予約注文 |
---|---|---|---|---|
Claudin18.2 | CL2-H52P7 NEW | Human Claudin-18.2 Full Length Protein-VLP (HEK293) | 免疫抗原 ELISA SPR/BLI 細胞レベルでの実験 CAR陽性検査 | |
Claudin18.2 | CL2-HF218 NEW | Fluorescent Human Claudin-18.2 Full Length Protein-VLP (HEK293) | ||
Claudin18.2 | CL2-H82E3 | Biotinylated Human Claudin-18.2 Protein, His,Avitag™ (active membrane protein) | 免疫抗原 ELISA SPR/BLI | |
Claudin18.2 | CL2-H5587 NEW | Human Claudin-18.2 Protein, His,Twin-Strep Tag (active membrane protein) | ||
VLP | VLP-N5213 | Virus-Like Particle (VLP) isotype control | VLPコントロール | |
VLP-NF2P4 | Fluorescent Virus-Like Particle (VLP) isotype control | |||
Buffer | DC-11 | 200x DDM CHS buffer | 膜タンパク質の可溶性と活性を維持 膜タンパク質または抗体の希釈 SPRまたはBLI法を使った実験バッファーの作成 |
ELISA/SPR/BLI/FACSに関するプロトコルを提供可能です。お気軽にお問い合わせください。
Immobilized Human Claudin-18.2 Full Length Protein-VLP (Cat. No. CL2-H52P7) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.2-3 ng/mL (QC tested).
Human Claudin-18.2 Full Length Protein-VLP (Cat. No. CL2-H52P7) captured on CM5 Chip via Anti-Claudin-18.2 antibody can bind Anti-Claudin-18.2 antibody with an affinity constant of 0.374 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
2e5 of Anti-Claudin-18.2 CAR-293 cells were stained with 100 μL of 3 μg/mL of Fluorescent Human Claudin-18.2 Full Length Protein-VLP (Cat. No.CL2-HF218) and negative control protein respectively, FITC signals was used to evaluate the binding activity (Routinely tested).
Immobilized Human Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5587) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).
Anti-Claudin-18.2 mAb captured on CM5 chip via anti-Human IgG (Fc) antibody can bind Human Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5587) with an affinity constant of 6.72 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|
This web search service is supported by Google Inc.